Clin2
NCT06987669Likely a fitNot yet recruiting

Gastric emptying in healthy people and GLP-1 drug users

Diabetes Type 2Obesity and Overweight

Part of Hormones & metabolism clinical trials.

This study looks at how fast the stomach empties in healthy volunteers and people taking semaglutide (a GLP-1 agonist drug for diabetes or weight loss). It may help understand how this drug affects digestion.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
155 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years old or older
  • You are a healthy volunteer OR you are currently using semaglutide (a GLP-1 agonist)
  • You have not had bariatric (weight loss) surgery
  • You do not have a hiatal hernia (a condition where part of the stomach pushes into the chest)
  • You are able to understand and agree to participate (give consent)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06734312Recruiting
Stomach procedure to maintain weight loss after GLP-1s

This study is for people who have lost weight using semaglutide or tirzepatide and are stopping that medication. It tests a stomach procedure (called mucosal ablation) to see if it can help you keep the weight off after stopping the drug.

Cary, North Carolina
NCT05071898Recruiting· Phase 1
Studying how genetics affect response to GLP-1 weight-loss drugs

This early-stage study looks at how genetic factors may change how people respond to a GLP-1 medicine (semaglutide). The goal is to learn who may benefit most and why, so future treatments can be better matched.

Lancaster, Pennsylvania
NCT07506356Recruiting
Stomach emptying in diabetes patients on GLP-1 drugs

This study uses an ultrasound to check how fast your stomach empties food. It looks at people with type 2 diabetes who have been taking a GLP-1 medication for at least three months.

Geneva, Canton of Geneva
NCT07251803Recruiting
GLP-1 medication stomach emptying study

This study uses an ultrasound to look at how full your stomach is after taking GLP-1 medications for diabetes or weight loss. It will help doctors understand if current fasting guidelines are safe before surgery or a colonoscopy.

Charleston, South Carolina
NCT06988397Not yet recruiting
Study of stomach emptying with diet and ultrasound

This study uses ultrasound to see how quickly your stomach empties after a meal. It aims to learn more about normal stomach function in healthy adults.

Warsaw, Masovian Voivodeship
NCT06659159Not yet recruiting
GLP-1 medicine effects on stomach emptying

This trial looks at how starting a GLP-1 medicine affects the amount of food left in your stomach and how quickly your stomach empties. It may help doctors better understand how these medicines work and how to use them safely.

Hear when a new Diabetes Type 2 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.